 Home > Encyclopedia > Orforglipron

Orforglipron

Orforglipron structure

CAS No:
2212020-52-3
Formula:
C48H48F2N10O5
Chemical Name:
Orforglipron
Synonyms:
1,2,4-Oxadiazol-5(2H)-one, 3-[(1S,2S)-1-[2-[[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2,3-dihydro-2-oxo-1H-imidazol-1-yl]-2,4,6,7-tetrahydro-4-methyl-5H-pyrazolo[4,3-c]pyridin-5-yl]carbonyl]-5-[(4S)-tetrahydro-2,2-dimethyl-2H-pyran-4-yl]-1H-indol-1-yl]-2-methylcy...;LY3502970;GLP-1 receptor agonist 1 USP/EP/BP;Orforglipron;Orforglipron（LY3502970）;LY3502970 (Orforglipron);3-((1S,2S)-1-(5-((S)-2,2-dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl)-2-methylcyclopropyl)-1,2,4-oxadiazol-5(4H)-one;OWL 833
Categories:
Active Pharmaceutical Ingredients > Hormones and the Endocrine System

Description

Orforglipron (LY3502970) (GLP-1 receptor agonist 1) is GLP-1 receptor agonist extracted from patent WO2018056453A1, Compound 67.

Orforglipron is an oral, non-peptide, small-molecule glucagon-like peptide-1 receptor agonist developed by Eli Lilly and Company as a weight-loss drug. Currently, the drug is still in Phase III clinical trials and has not yet received approval from the U.S. Food and Drug Administration (FDA). Eli Lilly's CEO expects the FDA to approve its investigational oral weight-loss drug, orforglipron, by March 2026, and to submit an application for the treatment of type 2 diabetes by the end of 2026.

Orforglipron Basic Attributes

Molecular Weight：

882.97

EC Number：

278-636-5

Color/Form：

Off-white to light yellow

Characteristics

Density：

1.50±0.1 g/cm3(Predicted)

PKA：

7.33±0.20(Predicted)

Critical Temperature & Pressure：

Store at -20°C

Orforglipron Use and Manufacturing

Orforglipron is a non-peptide oral glucagon-like peptide-1 receptor agonist (GLP-1RA) widely used in the management of type 2 diabetes mellitus (T2DM) and obesity. In T2DM patients, the drug reduces glycated haemoglobin (HbA1c) by up to 2.10%, facilitates weight loss of up to 10.1 kilograms, and reduces waist circumference by up to 8.7 centimetres. Studies in overweight or obese populations indicate weight loss of up to 13.0 kilograms. Adverse reactions include mild to moderate vomiting and nausea, particularly common following high-dose therapy or rapid dose escalation. Consequently, it should be used cautiously under medical supervision.

Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.

Recommended Suppliers of Orforglipron

Conier Chem&Pharma Limited Contact Supplier

CN
2 YRS

Business licensed

Trader Supplier of Dicobalt Octacarbonyl,(E,E)-Farnesol,(4S,5R)-4-Methyl-5-phenyloxazolidin-2-one,Geranyl linalool,farnesyl acetone

2212020-52-3 Orforglipron-LY3502970

Unit Price: $5-6 /KG FOB

CAS No.: 2212020-52-3

Content: 99%

Inquiry
Shaanxi Dideu Medichem Co. Ltd Contact Supplier

CN
5 YRS

Business licensed Certified factory

Manufactory Supplier of Chemical Pesticides,Food Additives,Agrochemicals,Active Pharm Ingredients,Flavors and Fragrances,Chemical Catalyst,Chemical Materials,Chem&Pharm Intermediates,Organic Intermediates,Feed Additive

High Quality Orforglipron 99% powder 2212020-52-3 Shaanxi Dideu Medichem Co.Ltd

Unit Price: $1 /G FOB

CAS No.: 2212020-52-3

Grade: Chemical Grade

Content: 99%

Inquiry
HANGZHOU PATIENCE CHEMICAL CO.,LTD Contact Supplier

CN
2 YRS

Business licensed

Trader Supplier of Semaglutide,Tirzepatide,Lixisenatide,Teduglutide,Retatrutide,Tirzepatide,Cagrilintide,Linaclotide,Octreotide Acetate,Sincalide,L- LYSINE MONOHYDRATE

Orforglipron (GLP-1 receptor agonist 1) -

CAS No.: 2212020-52-3

Grade: Pharmaceutical Grade

Inquiry
ChengDu TongChuangYuan Pharmaceutical Co Contact Supplier

CN
3 YRS

Business licensed Certified factory

Manufactory Supplier of Rimegepant Sulfate,Fezolinetant,Ubrogepant

Orforglipron

CAS No.: 2212020-52-3

Inquiry
Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd Contact Supplier

CN
1 YR

Business licensed

Trader Supplier of Peptides,API,Intermediate

Jinlan 98+ EP/BP/USP Orforglipron

CAS No.: 2212020-52-3

Grade: medical grade

Content: 98%

Inquiry